Generic Drugs in the Era of Artificial Intelligence: Bridging Cost, Quality, and Technology in Modern Pharmacotherapy

Elrashedy, Alyaa; Samy, Rokaya; Essam, Eman; Samy, Abdullah; Salim, Tasneem; Maher, Ahmed; Ahmed, Abdelrahman; Hasan, Mohamed E.; Awad, saeed

doi:10.21608/ejhst.2025.399621.1003

	Generic Drugs in the Era of Artificial Intelligence: Bridging Cost, Quality, and Technology in Modern Pharmacotherapy
Egyptian Journal of Health Sciences Technology
Articles in Press, Accepted Manuscript, Available Online from 11 August 2025
Document Type: Original Article
DOI: 10.21608/ejhst.2025.399621.1003
View on SCiNiTO
Authors
Alyaa Elrashedy ¹; Rokaya Samy²; Eman Essam²; Abdullah Samy²; Tasneem Salim²; Ahmed Maher²; Abdelrahman Ahmed²; Mohamed E. Hasan³; saeed Awad²
¹Department of Animal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, University of Sadat City, Egypt. Faculty of Applied Health Science, Borg Al Arab Technological University (BATU), Alexandria, Egypt
²Faculty of Applied Health Science, Borg Al Arab Technological University (BATU), Alexandria, Egypt
³Faculty of Applied Health Science, Borg Al Arab Technological University (BATU), Alexandria, Egypt Bioinformatics Department, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Egypt.
Abstract
Generic medications have become fundamental in addressing rising healthcare costs while maintaining patient safety and treatment efficacy. This detailed analysis explores the regulatory frameworks, scientific standards, and economic implications surrounding the practice of generic substitution. Particular emphasis is placed on the importance of pharmaceutical and bioequivalence standards, which ensure that generics match brand-name drugs in quality, safety, and performance. Furthermore, the paper highlights how cutting-edge technologies, especially bioinformatics and artificial intelligence, are transforming pharmaceutical research. These tools accelerate drug discovery, optimize clinical trial design, and support the development of both branded and generic medicines. The analysis also considers global trends, including the public’s perception of generic drugs and the role of government and industry in shaping acceptance. Ultimately, the discussion underscores the urgent need for transparent regulatory policies and educational campaigns to build trust and awareness. These efforts are vital to maximizing the impact of generic drugs as accessible, effective, and sustainable healthcare solutions worldwide.
Keywords
Bioinformatics; Drug Design; Drug Discovery; Generic drug; Healthcare


Statistics Article View: 83